| Research Topics: |
| INDEX |
| AI-chat 1 |
| PRIME 18 |
| aging 9 |
| body 2 |
| brain 10 |
| cancer 11 |
| censorship 1 |
| cognition 4 |
| covid-19 1 |
| culture 2 |
| dental 1 |
| diabetes 1 |
| gender 2 |
| genetics 2 |
| heart 8 |
| immune 5 |
| kidneys 6 |
| language 1 |
| lungs 7 |
| metabolism 3 |
| microbiome 3 |
| nutrition 6 |
| obesity 2 |
| pain 2 |
| physical 2 |
| politics 2 |
| pollution 2 |
| practice 1 |
| privacy 2 |
| psychology 4 |
| reproduction 1 |
| rights 1 |
| sleep 3 |
| tech 1 |
| virus 2 |
| war-confl |
|
Scanned: 2759 Evaluated: 288 Selected: 68 |
| LUNGS | ||||||||||||||||||||||||||||||
Mbr03-002 | Efficacy and Safety of Sitafloxacin-Containing Regimen for Improved Treatment of Nontuberculous Mycobacterial Lung Disease: A Multi-Center Retrospective Study | |||||||||||||||||||||||||||||
| Quote: | Conclusions Sitafloxacin-based regimens accelerate microbiological clearance and promote radiographic healing in NTM pulmonary disease with good safety, positioning it as a viable drug for improved treatment of NTM infections. ### Competing Interest Statement | |||||||||||||||||||||||||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.01.13.26343918v1 | |||||||||||||||||||||||||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.01.13.26343918v1.full-text | |||||||||||||||||||||||||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||||||||||||||||||||||||
| Search Authors: | Yiru Zhang Hongxin Fu Chenxia Zhang Bihan Xu Kefan Bi Meifang Yang Haiying Yu Yongtao Li Jing Guo Wei Wu Kaijin Xu Ying Zhang, | |||||||||||||||||||||||||||||
| CANCER LUNGS | ||||||||||||||||||||||||||||||
Mbr03-004 | Serum Tumor Marker Profiles in Interstitial Lung Diseases: Implications for Differential Diagnosis and Disease Severity Assessment | |||||||||||||||||||||||||||||
| Quote: | Conclusion CEA, CA199, and CA125 aid in distinguishing ILD subtypes, while CEA, NSE, and CYFRA 21-1 correlate with impaired gas exchange. The combined clinical and biomarker model demonstrated superior performance in discriminating IPF from CTD-ILD, highlighting its clinical potential. | |||||||||||||||||||||||||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.01.13.26344081v1 | |||||||||||||||||||||||||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.01.13.26344081v1.full-text | |||||||||||||||||||||||||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||||||||||||||||||||||||
| Search Authors: | Yingying Du Xuxiang Song Qunli Ding, | |||||||||||||||||||||||||||||
| IMMUNE LUNGS | ||||||||||||||||||||||||||||||
Mbr03-006 | Alveolar Immune Profiling Identifies Distinct Subphenotypes of Acute Respiratory Failure | |||||||||||||||||||||||||||||
| Quote: | One Sentence Summary This study identifies novel subphenotypes of acute respiratory failure that exhibit highly distinct immune signatures and associations with clinical outcomes. | |||||||||||||||||||||||||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.01.13.26344060v1 | |||||||||||||||||||||||||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.01.13.26344060v1.full-text | |||||||||||||||||||||||||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||||||||||||||||||||||||
| Search Authors: | Eric D. Morrell Ted Liu Marika Orlov Leonoor S. Boers Neha A. Sathe Chelsea Schmitz Mallorie Mitchem Anne Chaize Lucy Y. Gao Francis L. Mabrey Sarah E. Holton Pavan K. Bhatraju Akram Khan Catherine L. Hough Renee D. Stapleton Hlne van den Heuvel JanWillem Duitman Lieuwe D.J. Bos Mark M. Wurfel Carmen Mikacenic, | |||||||||||||||||||||||||||||
| LUNGS | ||||||||||||||||||||||||||||||
Mbr03-010 | Arousal network determines mean of systolic blood pressure and chemoreflex pathway determines dispersion of systolic blood pressure during N2 sleep in patients of moderate to severe obstructive sleep apnea | |||||||||||||||||||||||||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.01.12.25343259v1 | |||||||||||||||||||||||||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.01.12.25343259v1.full-text | |||||||||||||||||||||||||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||||||||||||||||||||||||
| Search Authors: | Biswagourav Nahak Dinu S Chandran Karan Madan Nasreen Akhtar, | |||||||||||||||||||||||||||||
| IMMUNE LUNGS | ||||||||||||||||||||||||||||||
Mbr03-012 | Longitudinal clinical proteomics reveals pneumonia type-specific protein biomarkers and autoantibodies | |||||||||||||||||||||||||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.01.12.26343938v1 | |||||||||||||||||||||||||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.01.12.26343938v1.full-text | |||||||||||||||||||||||||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||||||||||||||||||||||||
| Search Authors: | Anna Semenova Taylor A. Poor Johannes B. Mller-Reif Sai Rama Sridatta Prakki Phillip Geyer Martin Mck-Husl Lesca M. Holdt Daniel Teupser Matthias Mann Ali . Yildirim Richard G. Wunderink Alexander V. Misharin Ben D. Singer G.R. Scott Budinger Theodore S. Kapellos Herbert B. Schiller, | |||||||||||||||||||||||||||||
| CANCER LUNGS | ||||||||||||||||||||||||||||||
Mbr03-014 | Longitudinal Analysis of CYFRA 21-1 Levels in Patients with Pulmonary Nodules: Differential Trajectories Between Benign and Malignant Cases and Impact of Tumor Resection | |||||||||||||||||||||||||||||
| Quote: | Conclusions CYFRA 21-1 exhibits substantial within-patient variability over time, with trajectories that reflect disease state and treatment. These findings suggest that longitudinal monitoring of CYFRA 21-1analogous to PSA velocity in prostate cancer may offer improved diagnostic and prognostic insight in the evaluation of pulmonary nodules. Further studies in larger cohorts are warranted to validate these findings and explore clinical implementation of CYFRA trajectory analysis | |||||||||||||||||||||||||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.01.10.26343848v1 | |||||||||||||||||||||||||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.01.10.26343848v1.full-text | |||||||||||||||||||||||||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||||||||||||||||||||||||
| Search Authors: | Yency J. Forero Michael N. Kammer Kevin C. McGann Sheau-Chiann Chen Heidi Chen Samson Argaw Timothy A. Khalil Sanja L. Antic Yong Zou Zuo Lianrui Thomas A. Lasko Bennet A. Landman Stephen A. Deppen Eric L. Grogan Fabien Maldonado, | |||||||||||||||||||||||||||||
| PRIME HEART KIDNEYS LUNGS | ||||||||||||||||||||||||||||||
Min03-008 | Cardiovascular, renal and pulmonary risks of Long COVID: a retrospective cohort study stratified by age and sex | |||||||||||||||||||||||||||||
| Quote: | Conclusions Long COVID is associated with increased risk of adverse CRP outcomes, with relatively higher risks observed in younger adults. These findings support the need for continuing surveillance and risk-reduction strategies for cardiovascular and related disorders in Long COVID. | |||||||||||||||||||||||||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.01.14.26344156v1 | |||||||||||||||||||||||||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.01.14.26344156v1.full-text | |||||||||||||||||||||||||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||||||||||||||||||||||||
| Search Authors: | Akash Pradeep Martha L Carvour Srija M Sivamurugan Upinder Singh Alejandro P Comellas Sanjana Dayal, | |||||||||||||||||||||||||||||
| Search Words: |
| |||||||||||||||||||||||||||||
|
Updated weekly.
01/24/2026-02:51:25 AM
Javilk's Research Links Drop me a note to subscribe. What interests you? |